Zweegman, S., Schjesvold, F., Larocca, A., Tahri, S., Pautasso, C., Aguilar, G., Smirnov, P., Gray, K., Doyle, M., Boccadoro, M., Sonneveld, P., Donk, N. W. V. D., Mateos, M. (2025). Fixed-duration teclistamab and talquetamab for frail patients with newly diagnosed multiple myeloma: The EMN37 fitfix study. Blood. https://doi.org/10.1182/blood-2025-4064